Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery
Phase 2 Completed
63 enrolled 12 charts
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Phase 1 Completed
37 enrolled
A Follow-up Study of Women Evaluated and Treated for Infertility
Completed
12,193 enrolled
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
Phase 1 Completed
41 enrolled 20 charts
Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident
Completed
23,143 enrolled
Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment
Completed
16 enrolled
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
Completed
229 enrolled
The Incidence of Breast and Other Cancers Among Female Flight Attendants
Completed
6,093 enrolled
Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident
Completed
19,456 enrolled
Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
Phase 2 Completed
152 enrolled 16 charts
Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing
Completed
2,997 enrolled
Radiation Exposure and Thyroid Disease in Kazakhstan
Completed
117 enrolled
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Phase 2 Completed
24 enrolled 6 charts
Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
Phase 2 Completed
12 enrolled 4 charts
Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
Phase 2 Completed
20 enrolled 14 charts
A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Phase 2 Completed
13 enrolled 11 charts
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
Phase 2 Completed
25 enrolled 11 charts
Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Phase 2 Completed
41 enrolled 10 charts
Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer
Phase 2 Completed
41 enrolled 10 charts
Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Phase 2 Completed
39 enrolled 8 charts
Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer
Phase 2 Completed
19 enrolled 11 charts
Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine
Phase 2 Completed
20 enrolled 7 charts
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
Phase NA Completed
400 enrolled
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
Phase 1 Completed
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Phase 2 Completed
30 enrolled
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Phase 2 Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Phase 1 Completed
15 enrolled
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Phase 1 Completed
24 enrolled
Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
Phase 2 Completed
34 enrolled 8 charts
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
Phase NA Completed
40 enrolled
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
Phase 4 Completed
20 enrolled
The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients
Phase 2 Completed
20 enrolled